Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies-authors' reply
Aliment Pharmacol Ther
.
2017 Oct;46(7):705-706.
doi: 10.1111/apt.14269.
Authors
A Aksan
1
2
,
H Işık
3
,
H H Radeke
2
4
,
A Dignass
2
5
,
J Stein
2
6
Affiliations
1
Faculty of Health Sciences, Hacettepe University, Ankara, Turkey.
2
Interdisciplinary Crohn Colitis Centre Rhein-Main, Frankfurt/Main, Germany.
3
Faculty of Sciences, Hacettepe University, Ankara, Turkey.
4
Pharmazentrum frankfurt, Institute of Pharmacology and Toxicology, Hospital of the Goethe University, Frankfurt/Main, Germany.
5
Department of Gastroenterology, Agaplesion Markus Krankenhaus, Frankfurt/Main, Germany.
6
Department of Gastroenterology and Clinical Nutrition, DGD Clinics Sachsenhausen, Frankfurt/Main, Germany.
PMID:
28880453
DOI:
10.1111/apt.14269
No abstract available
Publication types
Letter
Comment
MeSH terms
Anemia
Hemoglobins*
Humans
Iron*
Substances
Hemoglobins
Iron